These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 14033525)

  • 1. Relief of depression within one day using an M.A.O. inhibitor and intravenous 5-HTP.
    KLINE NS; SACKS W
    Am J Psychiatry; 1963 Sep; 120():274-5. PubMed ID: 14033525
    [No Abstract]   [Full Text] [Related]  

  • 2. FURTHER STUDIES ON: ONE DAY TREATMENT OF DEPRESSION WITH 5-HTP.
    KLINE NS; SACKS W; SIMPSON GM
    Am J Psychiatry; 1964 Oct; 121():379-81. PubMed ID: 14211415
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of depression with an mao inhibitor followed by 5-HTP--an unfinished research project.
    Kline N; Sacks W
    Acta Psychiatr Scand Suppl; 1980; 280():233-41. PubMed ID: 6996430
    [No Abstract]   [Full Text] [Related]  

  • 4. Loss of antidepressant effect with long-term monoamine oxidase inhibitor treatment without loss of monoamine oxidase inhibition.
    Mann JJ
    J Clin Psychopharmacol; 1983 Dec; 3(6):363-6. PubMed ID: 6315778
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biosynthesis and metabolism of indolamines in the pineal organ of Lacerta (reptiles, larcertilians). II. Monoamine oxidase activity and incorporation of 3H-5-HTP and 3H-5-HT under normal and experimental conditions].
    Collin JP; Meiniel A
    Z Zellforsch Mikrosk Anat; 1973 Dec; 145(3):331-61. PubMed ID: 4543951
    [No Abstract]   [Full Text] [Related]  

  • 6. Depressed states and indolealkylamines.
    Coppen AJ
    Adv Pharmacol (1962); 1968; 6(Pt B):283-91. PubMed ID: 5301640
    [No Abstract]   [Full Text] [Related]  

  • 7. Etryptamine acetate in general practice.
    CHOGICH JC
    J Neuropsychiatr; 1961; 3():96-7. PubMed ID: 13879126
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain barrier to 5-HTP.
    Glassman A
    N Engl J Med; 1968 Feb; 278(5):281. PubMed ID: 5299836
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of inversion by demethylimipramine of motor depression induced by tetrabenazine].
    Lakoza GN
    Farmakol Toksikol; 1969; 32(4):406-10. PubMed ID: 5307899
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of geriatric patients with etryptamine acetate.
    KIESSLING AJ
    J Neuropsychiatr; 1961 Feb; 2(Suppl1)():64-5. PubMed ID: 13755873
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest of 5-hydroxytryptophan (5-HTP) as a neuroendocrine marker in depressive illness. A negative report.
    Ansseau M; Doumont A; Thiry D; Geenen V; Legros JJ
    Acta Psychiatr Belg; 1983; 83(1):50-6. PubMed ID: 6604395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the hypothalamo-pituitary-adrenal axis and the metabolism of serotonin in affective disorders. Therapeutic use of serotonin precursors (review)].
    Pérez de los Cobos Peris J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1986; 14(3):147-274. PubMed ID: 3526823
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-Hydroxytryptophan (5-HTP) uptake and decarboxylation in the kitten brain.
    Kitahama K; Jouvet A; Fujimiya M; Nagatsu I; Arai R
    J Neural Transm (Vienna); 2002 May; 109(5-6):683-9. PubMed ID: 12111460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.
    Byerley WF; Judd LL; Reimherr FW; Grosser BI
    J Clin Psychopharmacol; 1987 Jun; 7(3):127-37. PubMed ID: 3298325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Harold E. Himwich Memorial Lecture. Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders.
    Praag HM
    Biol Psychiatry; 1977 Feb; 12(1):101-31. PubMed ID: 300032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of endogenous depression with a new monoamine oxidase inhibitor].
    SATTES H; THIELE W
    Med Klin; 1962 Aug; 57():1458-60. PubMed ID: 14497477
    [No Abstract]   [Full Text] [Related]  

  • 18. A COMPARISON OF PHENOXYPROPAZINE AND AMYTRYPTILINE IN DEPRESSION.
    ROSE JT; LEAHY MR; PLOWMAN R
    Am J Psychiatry; 1963 Oct; 120():393-5. PubMed ID: 14069469
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.